379 related articles for article (PubMed ID: 35405150)
1. Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway.
Yan LS; Zhang SF; Luo G; Cheng BC; Zhang C; Wang YW; Qiu XY; Zhou XH; Wang QG; Song XL; Pan SY; Zhang Y
Metabolism; 2022 Jun; 131():155200. PubMed ID: 35405150
[TBL] [Abstract][Full Text] [Related]
2. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
3. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
He Q; Sha S; Sun L; Zhang J; Dong M
Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
[TBL] [Abstract][Full Text] [Related]
4. Thymoquinone attenuates hepatic lipid accumulation by inducing autophagy via AMPK/mTOR/ULK1-dependent pathway in nonalcoholic fatty liver disease.
Zhang D; Zhang Y; Wang Z; Lei L
Phytother Res; 2023 Mar; 37(3):781-797. PubMed ID: 36479746
[TBL] [Abstract][Full Text] [Related]
5. Vine tea total flavonoids activate the AMPK/mTOR pathway to amelioration hepatic steatosis in mice fed a high-fat diet.
Wang C; Yang F; Zeng W; Chen X; Qiu Z; Wang Q; Meng Y; Zheng G; Hu J
J Food Sci; 2024 May; 89(5):3019-3036. PubMed ID: 38517018
[TBL] [Abstract][Full Text] [Related]
6. Schizandrin A supplementation improves nonalcoholic fatty liver disease in mice fed a high-fat and high-cholesterol diet.
Jeong MJ; Kim SR; Jung UJ
Nutr Res; 2019 Apr; 64():64-71. PubMed ID: 30802724
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells.
Chu JH; Wang H; Ye Y; Chan PK; Pan SY; Fong WF; Yu ZL
World J Gastroenterol; 2011 May; 17(19):2379-88. PubMed ID: 21633637
[TBL] [Abstract][Full Text] [Related]
8. Exogenous galanin alleviates hepatic steatosis by promoting autophagy via the AMPK-mTOR pathway.
Zhu S; Wang S; Luo T
Arch Biochem Biophys; 2023 Aug; 744():109689. PubMed ID: 37429535
[TBL] [Abstract][Full Text] [Related]
9. Red Pepper Seeds Inhibit Hepatic Lipid Accumulation by Inducing Autophagy via AMPK Activation.
Lee YH; Kim HJ; You M; Kim HA
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36296933
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydropalmatine ameliorates hepatic steatosis in nonalcoholic fatty liver disease by switching lipid metabolism via AMPK-SREBP-1c-Sirt1 signaling axis.
Yin X; Liu Z; Wang J
Phytomedicine; 2023 Oct; 119():155005. PubMed ID: 37562090
[TBL] [Abstract][Full Text] [Related]
11. Neuregulin 4 alleviates hepatic steatosis via activating AMPK/mTOR-mediated autophagy in aged mice fed a high fat diet.
Zhu B; Mei W; Jiao T; Yang S; Xu X; Yu H; Ding Y; Guo S; Meng B; Zhao L; He M; Dong K; Guo H; Guo X; Zhang H; Dang R; Xiang G; Wen N
Eur J Pharmacol; 2020 Oct; 884():173350. PubMed ID: 32726654
[TBL] [Abstract][Full Text] [Related]
12. Sweroside alleviates hepatic steatosis in part by activating AMPK/mTOR-mediated autophagy in mice.
Ding Y; Chen Y; Hu K; Yang Q; Li Y; Huang M
J Cell Biochem; 2023 Jul; 124(7):1012-1022. PubMed ID: 37269482
[TBL] [Abstract][Full Text] [Related]
13. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
[TBL] [Abstract][Full Text] [Related]
14. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
15. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.
Quan HY; Kim DY; Kim SJ; Jo HK; Kim GW; Chung SH
Biochem Pharmacol; 2013 May; 85(9):1330-40. PubMed ID: 23435355
[TBL] [Abstract][Full Text] [Related]
16.
Bae S; Lee YH; Lee J; Park J; Jun W
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558538
[No Abstract] [Full Text] [Related]
17. Branched Chain Amino Acids Cause Liver Injury in Obese/Diabetic Mice by Promoting Adipocyte Lipolysis and Inhibiting Hepatic Autophagy.
Zhang F; Zhao S; Yan W; Xia Y; Chen X; Wang W; Zhang J; Gao C; Peng C; Yan F; Zhao H; Lian K; Lee Y; Zhang L; Lau WB; Ma X; Tao L
EBioMedicine; 2016 Nov; 13():157-167. PubMed ID: 27843095
[TBL] [Abstract][Full Text] [Related]
18. FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice.
Liu TY; Xiong XQ; Ren XS; Zhao MX; Shi CX; Wang JJ; Zhou YB; Zhang F; Han Y; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
Diabetes; 2016 Nov; 65(11):3262-3275. PubMed ID: 27504012
[TBL] [Abstract][Full Text] [Related]
19. Schisandrin B ameliorates non-alcoholic liver disease through anti-inflammation activation in diabetic mice.
Ma R; Zhan Y; Zhang Y; Wu L; Wang X; Guo M
Drug Dev Res; 2022 May; 83(3):735-744. PubMed ID: 34927282
[TBL] [Abstract][Full Text] [Related]
20. Protopanaxadiol ameliorates NAFLD by regulating hepatocyte lipid metabolism through AMPK/SIRT1 signaling pathway.
Li Y; Liu Y; Chen Z; Tang K; Yang L; Jiang Y; Wang J; Huang P; Wang J; Zheng P; Song H
Biomed Pharmacother; 2023 Apr; 160():114319. PubMed ID: 36724639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]